Mosaic ImmunoEngineering annual free cash flow
2011
2012
2013
2014
2015
2016
2017
2018
2019
Mosaic ImmunoEngineering Free Cash Flow (FCF) History (CPMV)
Mosaic ImmunoEngineering reported −$760,766 in free cash flow for fiscal 2019, an increase of $120,869 from the previous fiscal year.
View full Mosaic ImmunoEngineering company overviewMosaic ImmunoEngineering free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2019 | 2019-05-31 | −$760,766 | $120,869 | — | — |
| 2018 | 2018-05-31 | −$881,635 | $431,900 | — | — |
| 2017 | 2017-05-31 | −$1.3M | $264,749 | — | — |
| 2016 | 2016-05-31 | −$1.6M | −$231,958 | — | — |
| 2015 | 2015-05-31 | −$1.3M | $158,347 | — | — |
| 2014 | 2014-05-31 | −$1.5M | −$492,301 | — | — |
| 2013 | 2013-05-31 | −$1.0M | $1.4M | — | — |
| 2012 | 2012-05-31 | −$2.4M | $1.9M | — | — |
| 2011 | 2011-05-31 | −$4.3M | — | — | — |
Mosaic ImmunoEngineering quarterly free cash flow
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2018 | 2018-05-31 | −$209,352 | $176,714 | — | — |
| Q3 2018 | 2018-02-28 | −$187,890 | $43,097 | — | — |
| Q2 2018 | 2017-11-30 | −$255,471 | $19,114 | — | — |
| Q1 2018 | 2017-08-31 | −$228,922 | $192,975 | — | — |
| Q4 2017 | 2017-05-31 | −$386,066 | −$25,985 | — | — |
| Q3 2017 | 2017-02-28 | −$230,987 | $127,987 | — | — |
| Q2 2017 | 2016-11-30 | −$274,585 | $33,221 | — | — |
| Q1 2017 | 2016-08-31 | −$421,897 | $129,526 | — | — |
| Q4 2016 | 2016-05-31 | −$360,081 | −$26,997 | — | — |
| Q3 2016 | 2016-02-29 | −$358,974 | −$146,425 | — | — |
| Q2 2016 | 2015-11-30 | −$307,806 | $24,908 | — | — |
| Q1 2016 | 2015-08-31 | −$551,423 | −$83,444 | — | — |
| Q4 2015 | 2015-05-31 | −$333,084 | −$24,645 | — | — |
| Q3 2015 | 2015-02-28 | −$212,549 | $136,565 | — | — |
| Q2 2015 | 2014-11-30 | −$332,714 | −$5,726 | — | — |
| Q1 2015 | 2014-08-31 | −$467,979 | $52,153 | — | — |
| Q4 2014 | 2014-05-31 | −$308,439 | $31,181 | — | — |
| Q3 2014 | 2014-02-28 | −$349,114 | −$96,447 | — | — |
| Q2 2014 | 2013-11-30 | −$326,988 | −$469,347 | — | — |
| Q1 2014 | 2013-08-31 | −$520,132 | $42,312 | — | — |
| Q4 2013 | 2013-05-31 | −$339,620 | $295,453 | — | — |
| Q3 2013 | 2013-02-28 | −$252,667 | $2.6M | — | — |
| Q2 2013 | 2012-11-30 | $142,359 | $3.5M | — | — |
| Q1 2013 | 2012-08-31 | −$562,444 | $32,437 | — | — |
| Q4 2012 | 2012-05-31 | −$635,073 | — | — | — |
| Q3 2012 | 2012-02-29 | −$2.9M | — | — | — |
| Q2 2012 | 2011-11-30 | −$3.4M | — | — | — |
| Q1 2012 | 2011-08-31 | −$594,881 | — | — | — |
Mosaic ImmunoEngineering free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$1.5M to −$760,766, a net increase of $743,907. Mosaic ImmunoEngineering's latest reported quarter, Q4 2018, generated −$209,352 in free cash flow, an increase of $176,714 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Mosaic ImmunoEngineering filings at SEC.gov ↗